These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 18492847

  • 1. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides.
    Scholtens PA, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LM, Knol J, Vandenplas Y.
    J Nutr; 2008 Jun; 138(6):1141-7. PubMed ID: 18492847
    [Abstract] [Full Text] [Related]

  • 2. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
    Béghin L, Tims S, Roelofs M, Rougé C, Oozeer R, Rakza T, Chirico G, Roeselers G, Knol J, Rozé JC, Turck D.
    Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049
    [Abstract] [Full Text] [Related]

  • 3. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.
    Vandenplas Y, Ludwig T, Bouritius H, Alliet P, Forde D, Peeters S, Huet F, Hourihane J.
    Acta Paediatr; 2017 Jul; 106(7):1150-1158. PubMed ID: 28328065
    [Abstract] [Full Text] [Related]

  • 4. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.
    Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P.
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):580-8. PubMed ID: 18493215
    [Abstract] [Full Text] [Related]

  • 5. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated.
    Huet F, Abrahamse-Berkeveld M, Tims S, Simeoni U, Beley G, Savagner C, Vandenplas Y, Hourihane JO.
    J Pediatr Gastroenterol Nutr; 2016 Oct; 63(4):e43-53. PubMed ID: 27472478
    [Abstract] [Full Text] [Related]

  • 6. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
    Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LM, Redegeld FA, Willemsen LE, Garssen J.
    Pediatr Allergy Immunol; 2011 Aug; 22(5):537-42. PubMed ID: 21771085
    [Abstract] [Full Text] [Related]

  • 7. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants.
    Westerbeek EA, van den Berg A, Lafeber HN, Fetter WP, van Elburg RM.
    Br J Nutr; 2011 Jan; 105(2):268-74. PubMed ID: 20863418
    [Abstract] [Full Text] [Related]

  • 8. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels.
    Alliet P, Scholtens P, Raes M, Hensen K, Jongen H, Rummens JL, Boehm G, Vandenplas Y.
    Nutrition; 2007 Oct; 23(10):719-23. PubMed ID: 17664059
    [Abstract] [Full Text] [Related]

  • 9. Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review.
    Scholtens PA, Goossens DA, Staiano A.
    World J Gastroenterol; 2014 Oct 07; 20(37):13446-52. PubMed ID: 25309075
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
    Rodriguez-Herrera A, Mulder K, Bouritius H, Rubio R, Muñoz A, Agosti M, Lista G, Corvaglia L, Ludwig T, Abrahamse-Berkeveld M, Perez-Navero JL.
    Nutrients; 2019 Jul 05; 11(7):. PubMed ID: 31284424
    [Abstract] [Full Text] [Related]

  • 11. Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics.
    Raes M, Scholtens PA, Alliet P, Hensen K, Jongen H, Boehm G, Vandenplas Y, Rummens JL.
    Pediatr Allergy Immunol; 2010 Mar 05; 21(2 Pt 2):e377-85. PubMed ID: 20003064
    [Abstract] [Full Text] [Related]

  • 12. Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
    Xiao L, Gong C, Ding Y, Ding G, Xu X, Deng C, Ze X, Malard P, Ben X.
    Benef Microbes; 2019 Oct 14; 10(7):729-739. PubMed ID: 31965842
    [Abstract] [Full Text] [Related]

  • 13. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
    Vandenplas Y, de Halleux V, Arciszewska M, Lach P, Pokhylko V, Klymenko V, Schoen S, Abrahamse-Berkeveld M, Mulder KA, Porcel Rubio R, On Behalf Of The Voyage Study Group.
    Nutrients; 2020 Nov 20; 12(11):. PubMed ID: 33233658
    [Abstract] [Full Text] [Related]

  • 14. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula.
    Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG.
    Pediatr Allergy Immunol; 2006 Mar 20; 17(2):134-40. PubMed ID: 16618363
    [Abstract] [Full Text] [Related]

  • 15. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice.
    Szklany K, Wopereis H, de Waard C, van Wageningen T, An R, van Limpt K, Knol J, Garssen J, Knippels LMJ, Belzer C, Kraneveld AD.
    Nutr Neurosci; 2020 Nov 20; 23(11):896-910. PubMed ID: 30871432
    [Abstract] [Full Text] [Related]

  • 16. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants.
    Westerbeek EA, Hensgens RL, Mihatsch WA, Boehm G, Lafeber HN, van Elburg RM.
    Acta Paediatr; 2011 Nov 20; 100(11):1426-31. PubMed ID: 21449921
    [Abstract] [Full Text] [Related]

  • 17. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
    Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B.
    Am J Clin Nutr; 2022 Jan 11; 115(1):142-153. PubMed ID: 34617558
    [Abstract] [Full Text] [Related]

  • 18. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants.
    Scalabrin DM, Mitmesser SH, Welling GW, Harris CL, Marunycz JD, Walker DC, Bos NA, Tölkkö S, Salminen S, Vanderhoof JA.
    J Pediatr Gastroenterol Nutr; 2012 Mar 11; 54(3):343-52. PubMed ID: 21946836
    [Abstract] [Full Text] [Related]

  • 19. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH.
    Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V.
    J Pediatr Gastroenterol Nutr; 2005 Aug 11; 41(2):186-90. PubMed ID: 16056097
    [Abstract] [Full Text] [Related]

  • 20. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life.
    Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG.
    Br J Nutr; 2005 Nov 11; 94(5):783-90. PubMed ID: 16277782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.